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Abstract
Background: Monitoring hepatic blood flow and function might be crucial in treating critically ill patients. Intra-
abdominal hypertension is associated with decreased abdominal blood flow, organ dysfunction, and increased
mortality. The plasma disappearance rate (PDR) of indocyanine green (ICG) is considered to be a compound marker for
hepatosplanchnic perfusion and hepatocellular membrane transport and correlates well with survival in critically ill
patients. However, correlation between PDRICG and intra-abdominal pressure (IAP) remains poorly understood. The aim
of this retrospective study was to investigate the correlation between PDRICG and classic liver laboratory parameters, IAP
and abdominal perfusion pressure (APP). The secondary goal was to evaluate IAP, APP, and PDRICG as prognostic factors
for mortality.
Methods: A total of 182 paired IAP and PDRICG measurements were performed in 40 critically ill patients. The mean
values per patient were used for comparison. The IAP was measured using either a balloon-tipped stomach catheter
connected to an IAP monitor (Spiegelberg, Hamburg, Germany, or CiMON, Pulsion Medical Systems, Munich, Germany)
or a bladder FoleyManometer (Holtech Medical, Charlottenlund, Denmark). PDRICG was measured at the bedside using
the LiMON device (Pulsion Medical Systems, Munich, Germany). Primary endpoint was hospital mortality.
Results: There was no significant correlation between PDRICG and classic liver laboratory parameters, but PDRICG did
correlate significantly with APP (R = 0.62) and was inversely correlated with IAP (R = -0.52). Changes in PDRICG were
associated with significant concomitant changes in APP (R = 0.73) and opposite changes in IAP (R = 0.61). The IAP was
significantly higher (14.6 ± 4.6 vs. 11.1 ± 5.3 mmHg, p = 0.03), and PDRICG (10 ± 8.3 vs. 15.9 ± 5.2%, p = 0.02) and APP
(43.6 ± 9 vs. 57.9 ± 12.2 mmHg, p < 0.0001) were significantly lower in non-survivors.
Conclusions: PDRICG is positively correlated to APP and inversely correlated to IAP. Changes in APP are associated with
significant concomitant changes in PDRICG, while changes in IAP are associated with opposite changes in PDRICG,
suggesting that an increase in IAP may compromise hepatosplanchnic perfusion. Both PDRICG and IAP are correlated
with outcome. Measurement of PDRICG may be a useful additional clinical tool to assess the negative effects of
increased IAP on liver perfusion and function.
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Introduction
Intra-abdominal hypertension (IAH) and abdominal
compartment syndrome (ACS) have been associated with
organ dysfunction and mortality in critically ill patients
[1,2]. In terms of organ dysfunction, both intra-abdom-
inal and remote organs are involved. The effects of IAH
on cardiovascular, respiratory, and renal functions have
all been described in some detail [3]. Few data are avail-
able, however, on the effect of IAH on the liver [4], partly
due to the fact that hepatic blood flow and liver function
remain difficult to assess reliably at the bedside [5]. Liver
function is routinely evaluated by plasma concentrations
of liver enzymes physiologically restraint to certain cells
and subcellular compartments (aspartate aminotransfer-
ase (ASAT), alanine aminotransferase (ALAT), lactate
dehydrogenase (LDH), gamma-glutamyltranspeptidase
(gGT), alkaline phosphatase) and laboratory parameters
of liver synthesis (albumin, plasma cholinesterase, glu-
cose, coagulation factors with international normalized
ratio (INR)). However, all these tests supply only indirect
information on actual liver function.
The plasma disappearance rate of indocyanine green
(PDRICG) might be an alternative for bedside liver function
testing. After injection, indocyanine green (ICG) is distrib-
uted via the bloodstream and excreted by hepatocytes into
the bile. ICG does not enter enterohepatic recirculation
and is excreted completely by the gastrointestinal system.
Therefore, elimination of ICG is determined by cardiac
output (CO), hepatic blood flow, and hepatocellular
uptake [6]. While excretion into the bile can be impaired,
PDRICG can be unaffected. PDRICG has been shown to be
a good surrogate marker for liver function and hepatos-
planchnic perfusion [7-11]. Because PDRICG is one of very
few available markers for hepatic blood flow and function
and intra-abdominal pressure (IAP) is an important indi-
cator of a patient’s physiologic status, further investigation
of a possible interaction was deemed necessary because of
the scarce data currently available [12-15]. Therefore, the
first aim of the study was to investigate the correlation
between PDRICG and classic liver parameters. The second
aim was to analyze the correlation between IAP, abdom-
inal perfusion pressure (APP), and PDRICG as well as
between changes in IAP and APP and changes in PDRICG,
and finally, to determine the best threshold value for IAP,




The study consists of a retrospective data analysis from
measurements obtained in a case series of 40 critically ill
patients admitted to the medical ICU of a tertiary hospital
(Ziekenhuis Netwerk Antwerpen (ZNA) Stuivenberg
General Hospital, Antwerp, Belgium). Disease severity on
ICU admission was evaluated using the averaged simpli-
fied acute physiology score (SAPS-II), the acute physiology
and chronic health evaluation (APACHE-II) score, and the
sequential organ failure assessment (SOFA) score. The
indication to perform PDRICG was based on the clinical
judgement of the attending physician in charge. The study
was approved by the local institutional review board with-
out need for informed consent due to the retrospective
nature of the analysis.
Measurements and definitions
IAP was measured using either a balloon-tipped stomach
catheter connected to an IAP monitor (Spiegelberg,
Hamburg, Germany, or CiMON, Pulsion Medical Sys-
tems, Munich, Germany) or a FoleyManometer (Holtech
Medical, Charlottenlund, Denmark) via the bladder. IAP
was measured according to the World Society of the
Abdominal Compartment Syndrome (WSACS, http://
www.wsacs.org) guidelines and expressed in mmHg [16].
APP was calculated as mean arterial pressure (MAP)
minus IAP, and IAH was defined as a sustained or
repeated pathologic elevation of IAP ≥ 12 mmHg.
The PDRICG was obtained at the bedside using the
LiMON device (Pulsion Medical Systems, Munich, Ger-
many) connected to a disposable color sensor at the ear-
lobe or finger obtaining a chromodilution curve of 0.25
mg/kg of ICG solution (in a concentration of 5 mg ICG/
ml water) injected via a central venous catheter. In princi-
ple, the PDRICG is determined by mono-exponential trans-
formation of the original ICG concentration curve,
backward extrapolation to the time ‘zero’ (100%), and
describing the decay as percentage change over time. The
normal range of PDRICG is 18% to 25%/min in healthy
subjects. Together with PDRICG, the value of residual ICG
after 15 min can also be calculated as a percentage.
Classic liver tests (ASAT, ALAT, LDH, gGT, alkaline
phosphatase, bilirubin) and so-called liver synthesis tests
(albumin, plasma cholinesterase, glucose, and coagulation
factors with INR) were performed daily according to rou-
tine practice in our institution.
Statistical analysis
Descriptive statistics are presented as mean ± standard
deviation (SD) for normally distributed values and as
median (with interquartile range) in case of non-normal
distribution. Categorical variables were compared using
the chi-squared test, while continuous variables were
compared using Student’s t test or Mann Whitney U test
in case of non-normal distribution.
Statistical significance was defined at two-tailed
p value levels of 0.05. Calculations were performed
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using SPSS software version 17 (SPSS Inc., Chicago, IL,
USA). The coefficient of determination (R2) derived
from Pearson’s product-moment correlation (R) was
used for measurement of correlation between the mean
values of IAP, APP, and PDRICG obtained in each patient.
Because of repeated measurements in each patient, we
used weighted analysis, as described by Bland and
Altman [17,18] to investigate correlations.
To analyze whether changes in IAP or APP were
related to changes or trends in PDRICG, a four-quadrant
trend plot was constructed by plotting ΔIAP or ΔAPP
against ΔPDRICG at the same time interval by subtracting
the first from the last value. The concordance is calcu-
lated as the percentage of pairs with the same direction
of change. Based on previous reports, the concordance
should be >85% to 90%.
Receiver operating characteristics (ROC) curves were
calculated (for hospital mortality), and these curves
graphically describe the sensitivity of a diagnostic test
(true positive proportion) vs. 1 - specificity (true negative
proportion) and provide an improved measure of the
overall discriminatory power of a test as they assess all
possible threshold values. The WSACS recommends that
a good area under the ROC (AUROC) curve is at least
0.75; the best threshold needs to be identified with a sen-
sitivity and/or specificity of at least, or close to, 75%.
Primary endpoint was hospital mortality; secondary end-
points were ICU mortality and the development of IAH or
a low PDRICG. Outcome analysis and prediction was based
on the best threshold identified by AUROC for APP and
PDRICG (lowest value) and for IAP (highest value)




The Pearson correlations between PDRICG and classic
liver laboratory parameters, general hemodynamic para-
meters (MAP) and lactate, were not significant. A total of
182 paired IAP, APP, and PDRICG measurements were
performed in 40 patients; however, in two patients, only
one PDRICG value was obtained. Analysis according to
Pearson is shown in Figure 1 and revealed that the
PDRICG significantly correlated with APP (R = 0.62, p <
0.0001) (panel A) and inversely correlated with IAP (R =
-0.52, p = 0.001) (panel B); not surprisingly, the higher
the IAP, the lower is the APP (R = -0.64, p < 0.0001)
(panel C). Furthermore, changes in IAP (n = 38, since
only one paired measurement was obtained in two
patients) were associated with significant but opposite
changes in PDRICG with 76.3% concordance (R = -0.61, p
< 0.0001) (panel D), while changes in APP (n = 38) were
associated with significant concomitant changes in
PDRICG with 84.2% concordance (R = 0.73, p < 0.0001)
(panel E). These correlations were, however, only weak
and did not reach the R2 > 0.6 threshold.
Outcome
Comparing hospital survivors (n = 14) with non-survivors
(n = 26), we observed significantly higher values of IAP
(14.6 ± 4.6 vs. 11.1 ± 5.3 mmHg, p = 0.03) and signifi-
cantly lower values of APP (43.6 ± 9 vs. 57.9 ± 12.2
mmHg, p < 0.001) and PDRICG (10 ± 8.3 vs. 15.9 ± 5.2%,
p = 0.02) in non-survivors (Figure 2). Table 1 shows the
baseline patient characteristics according to outcome
(hospital mortality). Table 2 shows the worst values for
IAP, APP, and PDRICG in non-survivors. The incidence
of IAH (defined as a mean IAP ≥ 12 mmHg) and low
PDRICG (defined as <12%) was significantly higher in
non-survivors (Table 2).
Determination of thresholds
Analysis with ROC curves showed a significant AUROC
curve of 0.84, 0.74, and 0.82 respectively for SAPS-II,
APACHE-II, and SOFA scores. ROC curve analysis for
the highest IAP showed an AUROC of 0.74 (95% confi-
dence interval (CI), 0.55 to 0.93; p = 0.014). An IAP
< 12mmHg had a sensitivity of 80.8% and a specificity of
71.4% for good outcome (Figure 3, panel A). ROC curve
analysis for the lowest APP showed the best results with
an AUROC of 0.85 (95% CI, 0.71 to 0.99; p < 0.0001).
An APP ≥ 52.5 mmHg had a sensitivity of 71.4% and a
specificity of 80.8% for good outcome (Figure 3, panel B),
and finally, ROC curve analysis for the lowest PDR
showed an AUROC of 0.79 (95% CI, 0.64 to 0.94; p =
0.003). A PDR ≥ 12% had a sensitivity of 78.6% and a
specificity of 80.8% for good outcome (Figure 3, panel C).
Univariate analysis comparing baseline characteristics
according to IAP and PDRICG thresholds is shown in
Tables 3 and 4. Patients with IAH and a PDRICG < 12%
had significantly higher ICU and hospital mortality, and
the incidence of IAH was higher in patients with low
PDRICG and vice versa (Tables 5 and 6).
Evolution of main study parameters in relation to
outcome
The lower the PDRICG, the higher are the ICU and hospi-
tal mortality (Figure 4). Analysis with contingency tables
and the Fisher exact test showed significant differences in
outcome comparing patients with PDRICG below or higher
than 12% with a p value of 0.006 for both ICU and hospi-
tal mortality.
During the first week of ICU stay, survivors had higher
APP and PDRICG, lower IAP, and a less positive daily fluid
balance; in fact, survivors had a negative to zero fluid bal-
ance from day 2 (Figure 5). Non-survivors developed their
worst values for IAP, APP, and PDRICG later on during
the ICU stay (Table 2 and Figure 5).
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Figure 1 Regression plots. Pearson regression analysis comparing (A) mean intra-abdominal (IAP) and mean indocyanine green plasma
disappearance rate (PDRICG) per patient (n = 38), (B) mean abdominal perfusion pressure (APP) and mean PDRICG per patient (n = 38), (C) mean
IAP and mean APP per patient (n = 40) and Pearson regression analysis with four-quadrant plot comparing (D) mean changes in IAP (Delta IAP)
with mean changes in PDRICG (Delta PDRICG) per patient (n = 38), (E) mean changes in APP (Delta APP) with mean changes in PDRICG (Delta
PDRICG) per patient (n = 38).
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Discussion
The data of this retrospective analysis suggest that IAP is
inversely correlated with PDRICG. The rationale behind
this observation could be that increased IAP leading to
decreased APP and a drop in CO can result in compro-
mised splanchnic and thereby hepatic perfusion. As
PDRICG is dependent from both hepatocellular function
and effective sinusoidal perfusion, this consecutively leads
to reduced PDRICG. This is underlined in our study by the
good correlation between changes in IAP (and APP) with
changes in PDRICG. Rapid changes (within hours) are
most likely due to changes in sinusoidal perfusion rather
Figure 2 Box plots comparing survivors with non-survivors. (A) Highest IAP values. (B) Lowest APP values. (C) Lowest PDRICG values.
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than hepatocellular uptake of the dye. Measuring PDRICG
might therefore be a good additional tool to estimate influ-
ence of IAH on splanchnic perfusion in the individual
patient.
There are very few data on the relationship between
IAP and PDRICG. So far, Michelet et al. studied this sub-
ject prospectively in detail [13]. In 20 ARDS patients,
they looked at the influence of prone positioning on
IAP, PDRICG, and extravascular lung water compared to
the supine position, lying on a conventional foam mat-
tress vs. an air-cushioned mattress. They observed an
increase in IAP and a decrease in PDRICG in the prone
compared with the supine position on a conventional
foam mattress. The effect of proning on IAP was the
topic of a recent review [19]. The use of an air-cush-
ioned mattress had beneficial effects on IAP and PDRICG
during the prone position. Analyzing our data, we found
that PDRICG correlated significantly with IAP and even
more so with APP. Similar to the data of Michelet et al.
[13], changes in IAP were associated with significant
concomitant but opposite changes in PDRICG, suggest-
ing that an increase in IAP may compromise hepatos-
planchnic perfusion. Hering et al., however, did not
observe a decrease in PDRICG when patients were
proned despite the small increase in IAP from 10 to 13
mmHg [15].
Previous studies have shown that overall mortality
increases with lower values of PDRICG and that a PDRICG
threshold >14% is a good predictor of survival [20,21].
With respect to survival and using analysis by ROC with
AUROC curve as a measure of accuracy, Inal et al. [10]
demonstrated a superior sensitivity and specificity
(AUROC = 0.78) of PDRICG compared to the APACHE-
II score (AUROC = 0.64), SOFA score (AUROC = 0.56),
Table 2 Outcome predictors in survivors and non-survivors
Total Survivors (n = 14) Non-survivors (n = 26) p value
Highest IAP (mmHg) 13.4 ± 5.1 11.1 ± 5.3 14.6 ± 4.6 0.03
Day highest IAP 4 (2 to 6.8) 3 (1 to 5.3) 5 (2.8 to 7) NS
Lowest APP (mmHg) 48.6 ± 12.2 57.9 ± 12.2 43.6 ± 9 <0.0002
Day lowest APP 4 (1.3 to 7) 2 (1 to 3) 5 (2.8 to 7) 0.007
Lowest PDR (%) 12.1 ± 7.8 15.9 ± 5.2 10 ± 8.3 0.02
Day lowest PDR 5 (2 to 7) 2 (1 to 5) 5.5 (3.8 to 7) 0.03
IAH, n (%) 25 (62.5) 4 (28.6) 21 (80.8) 0.002
PDRICG < 12%, n (%) 23 (57.5) 3 (21.4) 20 (76.9) 0.001
Table 1 Patient demographics and baseline characteristics in survivors and non-survivors
Total Survivors Non-survivors p value
Patients, n (%) 40 14 (35) 26 (65)
Age (years) 59.8 ± 14.1 54.8 ± 16.1 62.4 ± 12.4 NS
Body mass index (kg/m2) 25.4 ± 6.3 27.7 ± 8.6 24.2 ± 4.4 NS
Gender (M/F) 1:1 1:1 1:1 NS
ICU stay (days) 14.5 (8.3 to 23.8) 10.5 (6.8 to 34.3) 16 (10 to 22.3) NS
Hospital stay (days) 27 (13.5 to 58.5) 51.5 (18.3 to 85) 20 (12.8 to 32.3) 0.059
SAPS II 45.3 ± 15.8 33.9 ± 9 51.4 ± 15.3 <0.0001
SAPS death probability (%) 43.1 ± 26.3 21.4 ± 15.7 54.7 ± 23.4 <0.0003
APACHE II 24 ± 14.2 18.3 ± 11.9 27 ± 14.6 0.06
SOFA 9 ± 3.5 6.6 ± 2.9 10.3 ± 3.1 0.001
SOFA respiratory 2.2 ± 1.1 1.6 ± 1.2 2.5 ± 0.9 0.02
SOFA coagulation 1.1 ± 1.3 0.8 ± 1.3 1.2 ± 1.4 NS
SOFA liver 1 ± 1.2 0.9 ± 1.3 1 ± 1.1 NS
SOFA cardiovascular 2.3 ± 1.6 1.3 ± 1.4 2.8 ± 1.4 0.002
SOFA neurological 0.8 ± 1.2 0.4 ± 0.9 1.1 ± 1.3 0.07
SOFA renal 1.4 ± 1.4 1.4 ± 1.5 1.4 ± 1.4 NS
MAP admission (mmHg) 70.9 ± 12.5 78.8 ± 13.6 66.7 ± 9.7 0.002
IAP admission (mmHg) 8.9 ± 3.9 7.8 ± 4.1 9.5 ± 3.7 NS
APP admission (mmHg) 59 ± 13.9 67.1 ± 16.1 54.7 ± 10.6 0.006
PDR admission (%) 16.4 ± 6.6 18 ± 5.1 15.6 ± 7.3 NS
Fluid balance admission (ml) 1,215 (−166 to 3,178) 592 (−656 to 2,705) 1,591 (−67 to 3,546) NS
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and bilirubin (AUROC = 0.62), while Sakka and Meier-
Hellmann [20] showed a superior sensitivity and specifi-
city to APACHE-II (AUROC = 0.68) and a comparable
sensitivity and specificity to SAPS-II (AUROC = 0.76). In
a prospective observational study in septic patients,
PDRICG < 8% predicted mortality with high sensitivity
and specificity [22]. This was confirmed by our data,
showing significantly lower values of PDRICG in non-
survivors. We also noted significantly higher IAP and
lower APP values in non-survivors, suggesting that low
IAP and high APP may be useful predictors of survival in
ICU patients and thus may also be interesting resuscita-
tion endpoints, especially, since we observed that changes
in IAP and APP were related to changes in PDRICG. In
non-survivors, the worst values of IAP, APP, and PDRICG
occurred later on during the course of the critical illness,
(A)        (B) 
 
(C) 
Figure 3 ROC curves. (A) Highest IAP. (B) Lowest APP. (C) Lowest PDRICG.
Malbrain et al. Annals of Intensive Care 2012, 2(Suppl 1):S19
http://www.annalsofintensivecare.com/content/2/S1/S19
Page 7 of 11
suggesting that non-resolution of IAH and sustained
poor hepatosplanchnic perfusion eventually may lead to
organ dysfunction and increased mortality. More
recently, Inal et al. showed in a retrospective analysis of
30 critically ill patients that IAP was significantly higher
(21.5 ± 2 mmHg vs. 11.7 ± 1.5 mmHg) and PDRICG was
significantly lower (10.9 ± 3.4% vs. 24.5 ± 6.8%) in non-
survivors compared to survivors [10].
Table 3 Demographics and baseline characteristics in patients with normal and low PDRICG
Lowest PDR ≥ 12 Lowest PDR < 12 p value
Patients, n (%) 17 (42.5) 23 (57.5)
Age (years) 59.6 ± 15.7 59.9 ± 13.1 NS
Body mass index (kg/m2) 26.4 ± 8.6 24.7 ± 4 NS
SAPS II 43.7 ± 14.9 46.4 ± 16.6 NS
SAPS death probability (%) 38.1 ± 27.4 46.7 ± 25.4 NS
APACHE II 21.9 ± 11.2 25.5 ± 16.1 NS
SOFA 7.9 ± 3.9 9.8 ± 3.1 NS
MAP admission (mmHg) 73.1 ± 15 69.3 ± 10.4 NS
IAP admission (mmHg) 7.5 ± 2.7 9.9 ± 4.3 0.05
APP admission (mmHg) 63 ± 15 56.1 ± 12.7 NS
PDR admission (%) 21.2 ± 5.9 12.9 ± 4.7 <0.0001
Table 4 Demographics and baseline characteristics in patients without and with IAH
No IAH IAH p value
Patients, n (%) 15 (37.5) 25 (62.5)
Age (years) 56.8 ± 16.8 61.5 ± 12.2 NS
Body mass index (kg/m2) 24.3 ± 4.1 26.1 ± 7.4 NS
SAPS II 39.5 ± 14 48.8 ± 16 0.07
SAPS death probability (%) 33.2 ± 28.5 49 ± 23.4 0.06
APACHE II 21.2 ± 16.5 25.6 ± 12.7 NS
SOFA 6.7 ± 3.1 10.4 ± 3 0.001
MAP admission (mmHg) 76.5 ± 14.1 67.6 ± 10.4 0.03
IAP admission (mmHg) 6.3 ± 2.1 10.5 ± 3.9 <0.0001
APP admission (mmHg) 68.2 ± 13.7 53.6 ± 11.1 0.001
PDR admission (%) 18.7 ± 6.8 15 ± 6.3 0.09
Table 5 Study endpoints in patients with normal and low PDRICG
Lowest PDR ≥ 12 (n = 17) Lowest PDR < 12 (n = 23) p value
Highest IAP (mmHg) 11 ± 4.5 15.1 ± 4.8 0.01
Lowest APP (mmHg) 55.6 ± 12.1 43.5 ± 9.6 0.001
Lowest PDR (%) 19.4 ± 5.8 6.6 ± 3.3 <0.0001
IAH, n (%) 6 (35.3) 19 (82.6) 0.003
ICU mortality, n (%) 4 (23.5) 18 (78.3) 0.001
Hospital mortality, n (%) 6 (35.3) 20 (87) 0.001
Table 6 Study endpoints in patients without and with IAH
No IAH (n = 15) IAH (n = 25) p value
Highest IAP (mmHg) 8.3 ± 1.9 16.4 ± 3.7 0.000
Lowest APP (mmHg) 59.9 ± 9.5 41.9 ± 8 <0.0001
Lowest PDR (%) 17.1 ± 7.1 9.1 ± 6.7 0.001
PDRICG < 12%, n (%) 4 (26.7) 19 (76) 0.003
ICU mortality, n (%) 5 (33.3) 17 (68) 0.04
Hospital mortality, n (%) 5 (33.3) 21 (84) 0.002
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* 
Figure 4 ICU and hospital mortality according to PDRICG category. The asterisk indicates a p value of 0.006 comparing ICU and hospital
(HOS) outcome in the group of patients with a PDRICG below and higher than 12%.
(A)          (B) 
 
(C)           (D)  
* 
 ° 
  * 
   * 
    # 
  *    °  * 
    ° 
Figure 5 Day-by-day evolution (presented as a plot of means with SD error bars) of important parameters. This is during the first week
of ICU stay stratified between survivors (open circles) and non-survivors (closed circles). (A) Evolution of IAP; the asterisk indicates a p value of
0.05. (B) Evolution of APP; the asterisk indicates a p value of 0.03, the degree sign indicates a p value of 0.06, and the number sign indicates a
p value of 0.08. (C) Evolution of daily fluid balance; the asterisk indicates a p value of 0.03 and the degree sign indicates a p value of 0.08.
(D) Evolution of PDRICG; the asterisk indicates a p value of 0.06 and the degree sign indicates a p value of 0.05.
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Our data show no significant correlation between
PDRICG and conventional liver laboratory tests in mixed
ICU patients. Two possible explanations for this observa-
tion might be that either PDRICG does not reflect liver
function at all or PDRICG gives additional information on
hepatocellular function and hepatosplanchnic perfusion
that is not ‘detected’ by the classic liver function tests.
However, due to its unique hepatic elimination, PDRICG
has been shown to be a good surrogate marker for liver
function and hepatosplanchnic perfusion; therefore, the
latter explanation seems more likely [10,11,20].
Our study has several limitations. First, the data sample
is quite small with only 40 patients studied. Second, the
analysis was retrospective, so we could not examine the
effects of interventions to lower IAP or to improve APP
on values of PDRICG. Third, our results are merely obser-
vational, so we cannot exclude other confounding factors
and deduct cause and effect from the observed relations.
Finally, important data on CO are missing, and this is an
important parameter in order to understand and interpret
the possible effects of IAP on liver flow (and thus also on
PDRICG), since previous studies showed that liver flow cor-
relates well with CO.
Conclusions
In this study, we demonstrated that PDRICG is not corre-
lated with classic liver laboratory tests; hence, it may pro-
vide additional information on hepatic blood flow and
hepatocellular function. We found a significant correlation
between PDRICG and IAP (and APP), suggesting that IAH
may impair hepatic blood flow and/or hepatic function as
it does also compromise other organ functions. Finally, we
found that there were significant differences between sur-
vivors and non-survivors regarding IAP, APP, and PDRICG.
An IAP below 12 mmHg, a PDRICG above 12%/min, and
an APP above 52.5 mmHg were predictive for good out-
come. PDRICG might be a good tool to estimate clinical
impact of IAH on splanchnic perfusion in selected criti-
cally ill patients.
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